Literature DB >> 19785522

Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.

Seung-Kuk Baek1, Kwang-Yoon Jung, Sun-Mook Kang, Soon-Young Kwon, Jeong-Soo Woo, Seung-Hyun Cho, Eun-Jae Chung.   

Abstract

BACKGROUND: Recurrence of regional cervical lymph nodes in patients with papillary thyroid carcinoma (PTC) is not uncommon, and is an important factor affecting the quality of life. The aims of this study are to investigate the risk factors that are associated with regional lymph node recurrence by comparing a group of patients with regional lymph node recurrence with a group without lymph node recurrence, and to analyze the clinical characteristics of recurrent regional lymph nodes in PTC.
METHODS: A retrospective analysis was performed on 189 patients who underwent surgery for PTC. By comparing a group with recurrent cervical lymph nodes (n = 33) with a group without recurrent cervical lymph nodes (n = 156), the risk factors for cervical lymph node recurrence were investigated and the clinical characteristics of recurrent cervical lymph nodes were analyzed.
RESULTS: Tumor size >2 cm, presence of extrathyroid tumor spread, high T stage, and presence of lymph node metastasis were associated with regional lymph node recurrence in univariate analysis (p < 0.05). Among them, only the N stage was significantly associated with regional recurrence in multivariate analysis (p < 0.05). The disease-free survival period was shorter in the lymph node metastasis-positive group, and the 10-year disease-free survival rate was 77.8% in the lymph node metastasis-negative group and 57.9% in the lymph node metastasis-positive group (p < 0.05). Among 130 patients without lymph node metastasis, regional recurrence occurred in 13 patients (10%), and the frequent levels of regional recurrence were levels II-IV of ipsilateral neck. In the patients with lymph node metastasis, the frequent levels were levels IV-VI of ipsilateral side and level II of the contralateral side.
CONCLUSION: Considering the low incidence of regional lymph node recurrence and the levels with frequent regional recurrence in patients without lymph node metastasis, elective neck dissection in all cases of total thyroidectomy may be immoderate. However, if any risk factors for regional recurrence, including large tumor size, presence of extrathyroid spread, high T stage, and presence of lymph node metastasis, are detected by preoperative and intraoperative evaluation, a systematic compartment-oriented lymphadenectomy should be considered because of the high possibility of regional recurrence.

Entities:  

Mesh:

Year:  2010        PMID: 19785522     DOI: 10.1089/thy.2008.0243

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  63 in total

1.  Prediction of cervical lymph node metastasis in patients with papillary thyroid cancer using combined conventional ultrasound, strain elastography, and acoustic radiation force impulse (ARFI) elastography.

Authors:  Jun-Mei Xu; Xiao-Hong Xu; Hui-Xiong Xu; Yi-Feng Zhang; Le-Hang Guo; Lin-Na Liu; Chang Liu; Xiao-Wan Bo; Shen Qu; Mingzhao Xing; Xiao-Long Li
Journal:  Eur Radiol       Date:  2015-11-11       Impact factor: 5.315

2.  Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.

Authors:  R Michael Tuttle; Hernan Tala; Jatin Shah; Rebecca Leboeuf; Ronald Ghossein; Mithat Gonen; Matvey Brokhin; Gal Omry; James A Fagin; Ashok Shaha
Journal:  Thyroid       Date:  2010-10-29       Impact factor: 6.568

3.  Candidates for limited lateral neck dissection among patients with metastatic papillary thyroid carcinoma.

Authors:  Byung Chul Kang; Jong-Lyel Roh; Jeong Hyun Lee; Kyung-Ja Cho; Gyungyub Gong; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

Review 4.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

Review 5.  Risk factors influencing the recurrence of papillary thyroid carcinoma: a systematic review and meta-analysis.

Authors:  Kai Guo; Zhuoying Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

6.  The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis.

Authors:  Yeo-Hoon Yoon; Hak Joon Kim; Jin Woo Lee; Jin Man Kim; Bon Seok Koo
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-06       Impact factor: 2.503

7.  Predictive factors for lymph node metastasis in solitary papillary thyroid carcinomas: a retrospective study.

Authors:  Fábio Muradás Girardi; Marinez Bizarro Barra; Cláudio Galleano Zettler
Journal:  Pathol Oncol Res       Date:  2014-05-02       Impact factor: 3.201

8.  Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.

Authors:  Patricia Aragon Han; Hyun-seok Kim; Soonweng Cho; Roghayeh Fazeli; Alireza Najafian; Hunain Khawaja; Melissa McAlexander; Benzon Dy; Meredith Sorensen; Anna Aronova; Thomas J Sebo; Thomas J Giordano; Thomas J Fahey; Geoffrey B Thompson; Paul G Gauger; Helina Somervell; Justin A Bishop; James R Eshleman; Eric B Schneider; Kenneth W Witwer; Christopher B Umbricht; Martha A Zeiger
Journal:  Thyroid       Date:  2016-03-07       Impact factor: 6.568

9.  Adequacy of pathology reports of specimens from patients with differentiated thyroid cancer.

Authors:  Ma Luisa Isidro; Gloria Lugo; Olga Fidalgo; Sara García-Arias
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

10.  Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.

Authors:  Arnoldo Piccardo; Matteo Puntoni; Gianluca Bottoni; Giorgio Treglia; Luca Foppiani; Mattia Bertoli; Ugo Catrambone; Anselmo Arlandini; Bassam Dib; Vania Altrinetti; Michela Massollo; Irene Bossert; Manlio Cabria; Francesco Bertagna; Luca Giovanella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-14       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.